Luton, Bedfordshire, United Kingdom, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed and published the final copy of the detailed research report on the Next Generation Sequencing Market.
“The global next generation sequencing market is expected to grow at 18% CAGR from 2019 to 2028. It is expected to reach above USD 32.81 billion by 2028 from USD 7.39 billion in 2019.”
Analyst View:
On the basis of product & service, the next generation sequencing market is categorized into presequencing products & services, NGS platforms, NGS consumables, services for NGS platforms, sequencing services, and bioinformatics. Surging multiple sequencing procedures and launch of easy-to-use consumables are expected to propel the growth of global next-generation sequencing market over the assessment time.
The global next generation sequencing market is classified by technology into synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing, and other sequencing technologies. Growing number of NGS platforms based on sequencing by synthesis technology is predicted to drive the global next-generation sequencing market in the upcoming years.
“The diagnostics segment is expected to witness high growth over the forecast period 2022 to 2028.”
Get Entry to pattern Report Pages of Next Generation Sequencing Market
https://exactitudeconsultancy.com/reports/2317/next-generation-sequencing-market/#request-a-sample
Instance Developments
In 2021, Illumina has collaborated with Myriad Genetics. Both companies have collaborated to create a kit-based version of the latters my Choice companion diagnostic (CDx) test. This collaboration will helpful to enhance the genomic profiles of tumour samples.
In 2021, BGI Group has received the CE mark approval for the Thalassemia Gene Detection Kit (Combinatorial Probe Anchor Synthesis Sequencing Method). This kit which can be used for the genetic diagnosis of á, â thalassemia and other hemoglobinopathy or for general population carrier screening.
Aggressive Dashboard- Companies Mentioned -> Illumina, Thermo Fisher Scientific, PerkinElmer, BGI Group, Agilent Technologies, Eurofins Scientific, Pacific Biosciences, Oxford Nanopore Technologies, QIAGEN, F. Hoffmann-La Roche AG, and GENEWIZ
Next Generation Sequencing Market Share Insights-> Europe (35%) accounts for the largest share of the global Next-Generation Sequencing Market due to significant presence of key market players in the region. After that Rest of the World to the 65% of global market respectively.
Market Segmentation Summary
By service type, the global next-generation sequencing market is divided into exome sequencing, targeted resequencing & custom gene panels, whole-genome sequencing & de novo sequencing, RNA-seq, and so on. RNA-Sequencing technology has slowly replaced microarray and tag-based transcriptome analyses with its relatively better benefits. RNA sequencing segment gives most prominent advantage like qualitative and quantitative. In the sector of biological research transcriptome analysis is more popular owing to its lees price. These aspects are likely to contribute the demand for global next-generation sequencing market.
The academic institutes & research centers segment dominated the overall market and accounted for a highest share in the revenue.
By end users, global next-generation sequencing market is graded as academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. Increasing number of collaborations between NGS manufacturers and academic & research institutes is anticipated to steer the growth of global next-generation sequencing market during the forecast period.
Next-Generation Sequencing Market Scope: Discount on report
| Next Generation Sequencing Market | Segmentation | |||
| Market Indicators: | Details | by Product and Service, | NGS Consumables Sequencing Services Exome & Targeted Resequencing & Custom Panels Whole Genome Sequencing & De Novo Sequencing RNA Sequencing Other Sequencing Services Presequencing Products & Services Library Preparation & Target Enrichment Quality Control NGS Platforms Illumina Thermo Fisher Scientific Oxford Nanopore Technologies Pacific Biosciences Other Platforms Bioinformatics Services For NGS Platforms | |
| Historical Data: | 2017-2021 | by Application | Diagnostics Cancer Diagnostics Infectious Disease Diagnostics Reproductive Health Diagnostics Other Diagnostic Applications Drug Discovery Agricultural & Animal Research Other Applications | |
| Forecast Period: | 2022-2028 | by End-User | Academic Institutes & Research Centers Pharmaceutical & Biotechnology Companies Hospitals & Clinics Other End Users | |
| Base Year: | 2021 | by Region | North America Europe Asia Pacific South America Middle East and Africa | |
| CAGR: | 18% | |||
| Market Size in 2020: | US $ 7.39 Bn | |||
| Market size in 2028: | US $ 32.81 Bn. | |||
Learn about the contribution of each segment summarized in concise info graphics and thorough descriptions. View a FREE PDF Sample Report
Regional Share Analysis->
Asia-Pacific is expected to exhibit highest growth rate throughout the next-generation sequencing forecast period. Furthermore, the favorable government policies and lower manpower costs in the region are predicted to enhance the growth of global next-generation sequencing market over the coming years.
See more on the report at: (70 Pages) on Next-Generation Sequencing Market:
https://exactitudeconsultancy.com/reports/2317/next-generation-sequencing-market
Some Important Points Answered in this Next-Generation Sequencing Market Report Are Given Below:
- Outline of product portfolio including product development, planning and positioning
- Details key operational strategies focusing on R&D strategies, corporate structures, localization strategies, manufacturing capabilities, and financial performance of various companies.
- Detailed analysis of market returns over the forecast period.
- Examine different market prospects using Porter's Five Forces Analysis, PEST and SWOT analysis.
- Study of the segment expected to dominate the market.
- A study on analysis of regions projected to register the highest growth during the forecast period
Get Discount on this growth report at:
**High Trending Experiences**
Gene Therapy Market
The global gene therapy market size is estimated at USD 4.83 billion in 2020 and is projected to reach USD 44.6 billion by 2029, at a CAGR of 28% for the forecasted year 2022 to 2029.
https://exactitudeconsultancy.com/reports/3443/gene-therapy-market/
Surgical Sealants Market
Global Surgical Sealants Market is expected to grow at USD 3.46 Billion in 2029 from USD 1.70 Billion in 2020, at a CAGR of 8.2% from 2022-2029.
https://exactitudeconsultancy.com/reports/3576/surgical-sealants-market/
Urinary Incontinence Market
The global Urinary Incontinence Market is expected to grow at 8.42% CAGR from 2020 to 2029. It is expected to reach above USD 6,718 million by 2029 from USD 2,985 million in 2020.
https://exactitudeconsultancy.com/reports/4349/urinary-incontinence-market/
Optical lens Market
The global Optical Lens Market is projected to reach USD 27,451 Million by 2029 from USD 14,438 Million in 2020, at a CAGR of 7.4% from 2022 to 2029.
https://exactitudeconsultancy.com/reports/5106/optical-lens-market/
